Filing Details
- Accession Number:
- 0001209191-22-049360
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-09-09 18:44:13
- Reporting Period:
- 2022-09-08
- Accepted Time:
- 2022-09-09 18:44:13
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1786255 | Icosavax Inc. | ICVX | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1884087 | Elizabeth Bekiroglu | C/O Icosavax, Inc. 1930 Boren Ave., Suite 1000 Seattle WA 98101 | General Counsel & Corp. Sec. | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2022-09-08 | 1,813 | $4.87 | 108,929 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Represents shares sold to cover the applicable withholding taxes upon settlement of restricted stock units issued to the Reporting Person and was effected pursuant to a Rule 10b5-1 trading plan.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.75 to $5.04. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.